Cargando…
Intravitreal bevacizumab as an adjunct to vitrectomy in advanced Eales’ disease
PURPOSE: This study aimed to report the use of intravitreal bevacizumab as an adjunctive treatment in two cases of advanced Eales’ disease with vitreous haemorrhage and tractional retinal detachment, prior to vitreoretinal surgery. METHOD: In two patients presenting with vitreous haemorrhage, retina...
Autores principales: | Thakar, Meenakshi, Bamrolia, Naina R., Raina, Usha Kaul, Ghosh, Basudeb |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345052/ https://www.ncbi.nlm.nih.gov/pubmed/22089976 http://dx.doi.org/10.1007/s12348-011-0049-3 |
Ejemplares similares
-
Role of Intravitreal Bevacizumab in Management of Eale’s Disease
por: Mehboob, Mohammad Asim, et al.
Publicado: (2018) -
Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
por: El-Batarny, Ashraf M
Publicado: (2008) -
Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
por: CP, Juarez, et al.
Publicado: (2013) -
Adjuvant Intravitreal Bevacizumab for Retinal Neovascularization in Eales’ Disease Associated With Latent Mycobacterium Tuberculosis
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023) -
Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
por: Goel, Neha, et al.
Publicado: (2018)